Chinese Journal of Pharmacovigilance ›› 2022, Vol. 19 ›› Issue (12): 1321-1324.
DOI: 10.19803/j.1672-8629.20210621
Previous Articles Next Articles
GAO Qinqin1, LIANG Guodong1, ZHOU Zexuan1, SHENG Wei1, XU Xiaoshuang2, LIU Weidong1,*, NA Heiya3,#
Received:
2021-06-19
Online:
2022-12-15
Published:
2022-12-21
CLC Number:
GAO Qinqin, LIANG Guodong, ZHOU Zexuan, SHENG Wei, XU Xiaoshuang, LIU Weidong, NA Heiya. Acute toxicity and long toxicity of Mongolian medicine sea-buckthorn syrup on 14-day-old SD rats[J]. Chinese Journal of Pharmacovigilance, 2022, 19(12): 1321-1324.
[1] LIANG GD, ZHAO FR.Situation of Mongolian medicine sea-buckthorn syrup and its modern research and development status[J]. Journal of Medicine & Pharmacy of Chinese Minorities(中国民族医药杂志), 2019, 25(2): 41-44. [2] HU SH. Yinshan Zhengyao (printed version)(饮膳正要)[M]. The seventh year of Jingtai in the Ming Dynasty (1456 A.D.). [3] XU ZL, HOU ZC, LAN TH.Preliminary study on vinegar willow juice[J]. Acta Nutrimenta Sinica(营养学报), 1956, 1(4): 333-350. [4] Department of Health of Inner Mongolia Autonomous Region. Standards for Mongolian Medicine in Inner Mongolia(内蒙古蒙成药标准)[M].1984: 382-383. [5] ZHU HZ.Drug liability and consumer protection[J]. Pharmaceutical Newsweek(医药新闻周刊), 1997, 16(3): 2581-2582. [6] ZHAO ZH, ZHANG L, LI WB, et al.Research progress on safety evaluation and toxicity of traditional chinese medicine[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2018, 24(20): 208-216. [7] ZHANG BL, CHENG YY, QU HB, et al.Innovation, research and industrialization of core technology system for secondary development of Chinese patent medicine[J]. Tianjin Journal of Traditional Chinese Medicine(天津中医药), 2015, 32(1): 1-3. [8] LIANG GD, WU QJ, NA HY.Effect of sea-buckthorn syrup on digestion in dyspesia mice model[J]. Journal of Pharmaceutical Research(药学研究), 2020, 39(9): 501-539. [9] LIANG GD, WU QJ, NA HY.Experimental studies on antitussive and expectorant effects of Sea-buckthorn Syrup[J]. Journal of Pharmaceutical Research(药学研究), 2020, 39(10): 562-574. [10] DONG TT, TIAN X, LU P, et al.Comparison and suggestion for implementation of“Technical guidelines for repeated drug administration toxicity testing”and“Technical guidelines for pharmacokinetic research” and ICH S4 and ICH S3A guidelines[J]. Drugs & Clinic(现代药物与临床), 2018,33(10): 2753-2757. [11] SUN ZY, ZHOU L.Strategy of study design to non-clinical safety evaluation of paediatruc medicines[J]. Chinese Journal of New Drugs(中国新药杂志), 2016, 25(21): 2473-2482. [12] CHEN QS, CAI SF, TAN YF, et al.Acute toxicity of mangrove plant lumnitzera racemosa extract on mice[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(2): 72-74,86. [13] GUO Y, HE W, LUO FX, et al.Study the acute toxicity and sub-acute toxicity of apocynum extract in mice by intragastric administration[J]. Xinjiang Medical Journal(新疆医学), 2019, 49(8): 770-773. [14] GAO ZW, ZHANG X, MO ZH, et al.Single dose toxicity of ficus microcarpa in mice[J]. Chinese Journal of Pharmacovigilance(中国药物警戒),2022,19(3): 1-10. [15] ZHANG Y.Toxicological Safety Evaluation of Bound Polyphenols of Seabuckthorn Berries[D]. Taiyuan Shanxi University(山西大学), 2020. |
[1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
[2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
[3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
[4] | SHI Yanlei, ZHANG Bing, WANG Yu, XU Zhuoxin, TIAN Min, MENG Min, SA Rina. Doxorubicin-Induced Cardiotoxicity Related to Regulation of Mitochondrial-Associated Membranes by PDK4 [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 863-868. |
[5] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
[6] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
[7] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
[8] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
[9] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
[10] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
[11] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
[12] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
[13] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
[14] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
[15] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||